Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056

MLA

Charles Paulding, et al. Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the MGluR5 Antagonist AFQ056. Jan. 2011. EBSCOhost, https://doi.org/10.1126/scitranslmed.3001708⟩.

APA

Charles Paulding, Jacques S. Beckmann, Yunsheng He, Nouchine Hadjikhani, Baltazar Gomez-Mancilla, Graeme Bilbe, Amandine Brun, Fei Chen, Donald Johns, Joanne M. Meyer, Kim Cornish, Maria Giulia Torrioli, Janice Branson, Annette Floesser, Talita Hilse, Randi J Hagerman, Danielle Martinet, Sébastien Jacquemont, Giovanni Neri, … Aurore Curie. (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. https://doi.org/10.1126/scitranslmed.3001708⟩

Chicago

Charles Paulding, Jacques S. Beckmann, Yunsheng He, Nouchine Hadjikhani, Baltazar Gomez-Mancilla, Graeme Bilbe, Amandine Brun, et al. 2011. “Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the MGluR5 Antagonist AFQ056,” January. doi:10.1126/scitranslmed.3001708⟩.